Biotechnology Assets, S.A. (BST:041)

Germany flag Germany · Delayed Price · Currency is EUR
0.216
-0.003 (-1.37%)
At close: Feb 26, 2026
-14.29%
Market Cap 15.55M
Revenue (ttm) 3.05M
Net Income (ttm) -2.08M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.222
Previous Close 0.219
Day's Range 0.207 - 0.222
52-Week Range 0.113 - 0.524
Beta n/a
RSI 51.57
Earnings Date Apr 7, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer... [Read more]

Industry Pharmaceutical Preparations
CEO Jaime Feced Rubio
Employees 30
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol 041
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.